Cohance Lifesciences Limited
COHANCE
Ранг среди акций
#6383
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Цена акции
$5.05
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$1.93B
Изменение (1 день)
-1.44%
Изменение (1 год)
-57.38%
Страна
IN
Торговля Cohance Lifesciences Limited (COHANCE)
Категория
Healthcare
EPS для Cohance Lifesciences Limited (COHANCE)
EPS по состоянию на June 2025 TTM: $0.11
Согласно последним финансовым отчетам и цене акций Cohance Lifesciences Limited, текущий EPS компании (TTM) составляет $0.11. В конце 2024 EPS компании составлял $0.14, меньше, чем показателю 2023 года, равному $0.20.
История EPS компании Cohance Lifesciences Limited с 2019 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
